1. Home
  2. INAB vs GURE Comparison

INAB vs GURE Comparison

Compare INAB & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • GURE
  • Stock Information
  • Founded
  • INAB 2016
  • GURE 2006
  • Country
  • INAB United States
  • GURE China
  • Employees
  • INAB N/A
  • GURE N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • GURE Major Chemicals
  • Sector
  • INAB Health Care
  • GURE Industrials
  • Exchange
  • INAB Nasdaq
  • GURE Nasdaq
  • Market Cap
  • INAB 9.1M
  • GURE 9.5M
  • IPO Year
  • INAB 2021
  • GURE 1992
  • Fundamental
  • Price
  • INAB $2.00
  • GURE $0.70
  • Analyst Decision
  • INAB Strong Buy
  • GURE
  • Analyst Count
  • INAB 2
  • GURE 0
  • Target Price
  • INAB $108.00
  • GURE N/A
  • AVG Volume (30 Days)
  • INAB 45.9K
  • GURE 58.0K
  • Earning Date
  • INAB 11-11-2025
  • GURE 08-13-2025
  • Dividend Yield
  • INAB N/A
  • GURE N/A
  • EPS Growth
  • INAB N/A
  • GURE N/A
  • EPS
  • INAB N/A
  • GURE N/A
  • Revenue
  • INAB N/A
  • GURE $13,919,011.00
  • Revenue This Year
  • INAB N/A
  • GURE N/A
  • Revenue Next Year
  • INAB N/A
  • GURE N/A
  • P/E Ratio
  • INAB N/A
  • GURE N/A
  • Revenue Growth
  • INAB N/A
  • GURE N/A
  • 52 Week Low
  • INAB $1.91
  • GURE $0.50
  • 52 Week High
  • INAB $16.70
  • GURE $1.47
  • Technical
  • Relative Strength Index (RSI)
  • INAB 39.35
  • GURE 48.45
  • Support Level
  • INAB $1.91
  • GURE $0.66
  • Resistance Level
  • INAB $2.20
  • GURE $0.75
  • Average True Range (ATR)
  • INAB 0.11
  • GURE 0.06
  • MACD
  • INAB -0.01
  • GURE -0.01
  • Stochastic Oscillator
  • INAB 23.08
  • GURE 30.50

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About GURE Gulf Resources Inc. (NV)

Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.

Share on Social Networks: